NUMI:CC News and Press, Numinus Wellness Inc. From 03/30/23

Numinus to Host Q2 2023 Results Conference Call on April 13, 2023 Canada NewsWire VANCOUVER, BC , March 30, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatmen...

Numinus Launches the Practitioner Certification Pathway - a Complete Psychedelic-Assisted Therapy Training Program Canada NewsWire VANCOUVER, BC , March 27, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a me...

Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023 Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023 Canada NewsWire VANCOUVER, BC , March 22, 2023 /C...

Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023 Canada NewsWire VANCOUVER, BC , March 21, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advanc...

Numinus Wellness Inc. Executives to Present on Panel at Upcoming South by Southwest Conference Canada NewsWire CEO and founder, Payton Nyquvest , to be featured on panel titled "Music as Medicine: Music as a Tool For Healing" alongside Dr. Reid Robison , Charlotte ...

Numinus to Participate in a Water Tower Research Fireside Chat on Tuesday, February 28, 2023 Canada NewsWire VANCOUVER, BC , Feb. 24, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company adv...

Numinus Expands Research Capabilities with new Phoenix Clinical Research Site Canada NewsWire The Phoenix Site is Numinus' Third Research Facility in the US VANCOUVER, BC , Feb. 17, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTCQX: ...

Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders Canada NewsWire VANCOUVER, BC , Feb. 15, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care com...

Numinus Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea Canada NewsWire Clinical trial will be the first to test whole Psilocybe mushrooms for safety and efficacy in a cl...

Numinus Wellness Inc. Reports Q1 2023 Results Canada NewsWire Q1 2023 revenues grew 618% year-over-year to $5.7 million Q1 2023 gross margin grew to 41.9% from 31.5% in prior quarter Gross profit of $2.4 million , an increase of $1.1 million from ...